A metabolite of estriol
Related Products
Parent Compound(s)
10006484Estriol
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Estriol 3-β-D-Glucuronide (sodium salt)

Item No. 14827

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
16α,17β-dihydroxyestra-1,3,5(10)-trien-3-yl, β-D-glucopyranosiduronic acid, monosodium salt
CAS Number
15087-06-6
Synonyms
  • Estriol sodium 3-glucuronate
Molecular Formula
C24H32O9 • Na
Formula Weight
487.5
Purity
≥95%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: slightly solubleMethanol: slightly soluble
SMILES
O[C@H]1[C@H](O)C[C@@]2([H])[C@]([C@]3([H])CC[C@@]21C)([H])CCC4=C3C=CC(O[C@H]5[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O5)=C4.[Na]
InChi Code
InChI=1S/C24H32O9.Na/c1-24-7-6-13-12-5-3-11(32-23-19(28)17(26)18(27)20(33-23)22(30)31)8-10(12)2-4-14(13)15(24)9-16(25)21(24)29;/h3,5,8,13-21,23,25-29H,2,4,6-7,9H2,1H3,(H,30,31);/t13-,14-,15+,16-,17+,18+,19-,20+,21+,23-,24+;/m1./s1
InChi Key
OMEVKFHIFIXRHB-NPSQBYGWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $54

    Add

    5 mg

    $238

    Add

    10 mg

    $418

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Estriol 3-β-D-glucuronide is a metabolite of estriol (Item No. 10006484).1 It is formed from estriol by the UDP-glucuronosyltransferase (UGT) isoform UGT1A10. Estriol 3-β-D-glucuronide binds to basolateral and canalicular liver plasma membranes with Kd values of 85 and 164 µM, respectively.2 It competitively inhibits the hydrolysis of 4-methylumbelliferyl-β-D-glucuronide (4Mu-GlcU; Item No. 17203) and is a substrate for hydrolysis by Klotho-human IgG1 Fc protein (KLFc).3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sneitz, N., Vanhermo, M., Mosorin, J., et al. Regiospecificity and stereospecificity of human UDP-glucuronosyltransferases in the glucuronidation of estriol, 16-epiestriol, 17-epiestriol, and 13-epiestradiol. Drug Metab. Dispos. 41(3), 582-591 (2013).

    2. Changchit, A., Durham, S.K., and Vore, M. Characterization of [3H]estradiol-17β-(β-D-glucuronide) binding sites in basolateral and canalicular liver plasma membranes. Biochem. Pharmacol. 40(6), 1219-1225 (1990).

    3. Tohyama, O., Imura, A., Freund, J.N., et al. Klotho is a novel β-glucuronidase capable of hydrolyzing steroid β-glucuronides. The Journal of Biological Chemisty 279(11), 9777-9784 (2004).

    Product Citations

    Raps, M., Kleider, C., and Lehmann, L. Quantitative analysis of 34 sex (pro)hormones, conjugates and bioactive oxidation products thereof in human plasma by GC- and LC-MS/MS and systematic investigation of overestimations of analyte concentrations not accounted for by method validation. Steroids 208:109441, (2024).